Abstract
The envelope glycoprotein E2 of classical swine fever virus (CSFV) is widely used as a marker for measuring vaccine efficacy and antibody titer. The glycosylation profile of E2 may affect the immunogenicity of the vaccine and the timing of re-vaccination. In this study, a human embryonic kidney cell line was used to secrete fully-glycosylated CSFV E2, which was then coated onto ELISA plates without purification or adjustment.The resulting E2-secreting medium-direct-coating (E2-mDc) ELISA was successfully used to measure anti-E2 antibody titers in vaccinated and field pig sera samples. Compared with a virus neutralization test (as standard), the E2-mDc ELISA was found to be more accurate (90%) than a commercial CSFV antibody diagnostic kit (62%). In conclusion, the mammalian cell-secreted antigen can provide cheap, accurate and effective assays for vaccine efficacy and disease diagnoses.
Original language | English |
---|---|
Pages (from-to) | 107-109 |
Number of pages | 3 |
Journal | Veterinary Journal |
Volume | 205 |
Issue number | 1 |
DOIs | |
Publication status | Published - Jul 1 2015 |
Keywords
- Classical swine fever virus
- E2
- Glycosylation
- Mammalian expression
- Medium-direct-coating ELISA
ASJC Scopus subject areas
- Animal Science and Zoology
- General Veterinary